Dihexa is a small, orally active peptide derived from angiotensin IV, studied for its interaction with the hepatocyte growth factor (HGF)/c-Met receptor system in the brain. This signaling pathway is involved in synaptogenesis—the formation of new synaptic connections between neurons. By potentiating HGF/c-Met signaling, dihexa is thought to support pathways involved in neuronal connectivity and cognitive processing at a cellular level, an area of ongoing research interest in neuroscience. EdgeRx offers dihexa through a clinician-supervised protocol, prescribed by licensed physicians for eligible patients as part of an individualized cognitive performance plan.